Global Whole Exome Sequencing Service Supply, Demand and Key Producers, 2026-2032

July 2026 | 150 pages | ID: GD937AAEB21FEN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Whole Exome Sequencing Service market size is expected to reach $ 5917 million by 2032, rising at a market growth of 11.3% CAGR during the forecast period (2026-2032).

Whole Exome Sequencing (WES) Service is a specialized high-throughput sequencing service focused on analyzing the exonic regions of the genome, which comprise the protein-coding portions accounting for approximately 1%?2% of the human genome. This service is widely used in genetic research, rare disease diagnostics, cancer mutation profiling, and precision medicine. By employing targeted capture and deep sequencing technologies, WES enables the comprehensive detection of genetic variants such as single nucleotide variants (SNVs) and small insertions/deletions (indels), offering a cost-effective yet information-rich approach. A standard WES service includes sample preparation, library construction, target enrichment, sequencing, quality control, variant calling, functional annotation, and clinical interpretation. Whole Exome Sequencing is a powerful tool for identifying disease-associated mutations, discovering novel genes, and guiding personalized treatment strategies, playing a crucial role in both medical genetics and translational research.

This report studies the global Whole Exome Sequencing Service demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Whole Exome Sequencing Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Whole Exome Sequencing Service that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Whole Exome Sequencing Service total market, 2021-2032, (USD Million)
Global Whole Exome Sequencing Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Whole Exome Sequencing Service total market, key domestic companies, and share, (USD Million)
Global Whole Exome Sequencing Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global Whole Exome Sequencing Service total market by Type, CAGR, 2021-2032, (USD Million)
Global Whole Exome Sequencing Service total market by Application, CAGR, 2021-2032, (USD Million)

This report profiles major players in the global Whole Exome Sequencing Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novogene, Eurofins Scientific, CD Genomics, Signios Bio, Macrogen, Roche, BGI, Psomagen, Centogene, Natera, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Whole Exome Sequencing Service market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Whole Exome Sequencing Service Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Whole Exome Sequencing Service Market, Segmentation by Type:
  • Clinical Whole Exome Sequencing
  • Research Whole Exome Sequencing
  • Others
Global Whole Exome Sequencing Service Market, Segmentation by Application:
  • Hospitals
  • Biopharma Companies
  • Academic and Research Organizations
  • Others
Companies Profiled:
  • Novogene
  • Eurofins Scientific
  • CD Genomics
  • Signios Bio
  • Macrogen
  • Roche
  • BGI
  • Psomagen
  • Centogene
  • Natera
  • Personalis
  • GENEWIZ
  • LabCorp
  • Brooks Life Sciences
  • Illumina
  • Berry Genomics
Key Questions Answered
1. How big is the global Whole Exome Sequencing Service market?
2. What is the demand of the global Whole Exome Sequencing Service market?
3. What is the year over year growth of the global Whole Exome Sequencing Service market?
4. What is the total value of the global Whole Exome Sequencing Service market?
5. Who are the Major Players in the global Whole Exome Sequencing Service market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Whole Exome Sequencing Service Introduction
1.2 World Whole Exome Sequencing Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Whole Exome Sequencing Service Total Market by Region (by Headquarter Location)
  1.3.1 World Whole Exome Sequencing Service Market Size by Region (2021-2032), (by Headquarter Location)
  1.3.2 United States Based Company Whole Exome Sequencing Service Revenue (2021-2032)
  1.3.3 China Based Company Whole Exome Sequencing Service Revenue (2021-2032)
  1.3.4 Europe Based Company Whole Exome Sequencing Service Revenue (2021-2032)
  1.3.5 Japan Based Company Whole Exome Sequencing Service Revenue (2021-2032)
  1.3.6 South Korea Based Company Whole Exome Sequencing Service Revenue (2021-2032)
  1.3.7 ASEAN Based Company Whole Exome Sequencing Service Revenue (2021-2032)
  1.3.8 India Based Company Whole Exome Sequencing Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Whole Exome Sequencing Service Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Major Market Trends

2 DEMAND SUMMARY

2.1 World Whole Exome Sequencing Service Consumption Value (2021-2032)
2.2 World Whole Exome Sequencing Service Consumption Value by Region
  2.2.1 World Whole Exome Sequencing Service Consumption Value by Region (2021-2026)
  2.2.2 World Whole Exome Sequencing Service Consumption Value Forecast by Region (2027-2032)
2.3 United States Whole Exome Sequencing Service Consumption Value (2021-2032)
2.4 China Whole Exome Sequencing Service Consumption Value (2021-2032)
2.5 Europe Whole Exome Sequencing Service Consumption Value (2021-2032)
2.6 Japan Whole Exome Sequencing Service Consumption Value (2021-2032)
2.7 South Korea Whole Exome Sequencing Service Consumption Value (2021-2032)
2.8 ASEAN Whole Exome Sequencing Service Consumption Value (2021-2032)
2.9 India Whole Exome Sequencing Service Consumption Value (2021-2032)

3 WORLD WHOLE EXOME SEQUENCING SERVICE COMPANIES COMPETITIVE ANALYSIS

3.1 World Whole Exome Sequencing Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Whole Exome Sequencing Service Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Whole Exome Sequencing Service in 2025
  3.2.3 Global Concentration Ratios (CR8) for Whole Exome Sequencing Service in 2025
3.3 Whole Exome Sequencing Service Company Evaluation Quadrant
3.4 Whole Exome Sequencing Service Market: Overall Company Footprint Analysis
  3.4.1 Whole Exome Sequencing Service Market: Region Footprint
  3.4.2 Whole Exome Sequencing Service Market: Company Product Type Footprint
  3.4.3 Whole Exome Sequencing Service Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Whole Exome Sequencing Service Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Whole Exome Sequencing Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
  4.1.2 United States VS China: Whole Exome Sequencing Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Whole Exome Sequencing Service Consumption Value Comparison
  4.2.1 United States VS China: Whole Exome Sequencing Service Consumption Value Comparison (2021 & 2025 & 2032)
  4.2.2 United States VS China: Whole Exome Sequencing Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Whole Exome Sequencing Service Companies and Market Share, 2021-2026
  4.3.1 United States Based Whole Exome Sequencing Service Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Whole Exome Sequencing Service Revenue, (2021-2026)
4.4 China Based Companies Whole Exome Sequencing Service Revenue and Market Share, 2021-2026
  4.4.1 China Based Whole Exome Sequencing Service Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Whole Exome Sequencing Service Revenue, (2021-2026)
4.5 Rest of World Based Whole Exome Sequencing Service Companies and Market Share, 2021-2026
  4.5.1 Rest of World Based Whole Exome Sequencing Service Companies, Headquarters (Province, Country)
  4.5.2 Rest of World Based Companies Whole Exome Sequencing Service Revenue (2021-2026)

5 MARKET ANALYSIS BY TYPE

5.1 World Whole Exome Sequencing Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
  5.2.1 Clinical Whole Exome Sequencing
  5.2.2 Research Whole Exome Sequencing
  5.2.3 Others
5.3 Market Segment by Type
  5.3.1 World Whole Exome Sequencing Service Market Size by Type (2021-2026)
  5.3.2 World Whole Exome Sequencing Service Market Size by Type (2027-2032)
  5.3.3 World Whole Exome Sequencing Service Market Size Market Share by Type (2027-2032)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Whole Exome Sequencing Service Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
  6.2.1 Hospitals
  6.2.2 Biopharma Companies
  6.2.3 Academic and Research Organizations
  6.2.4 Others
6.3 Market Segment by Application
  6.3.1 World Whole Exome Sequencing Service Market Size by Application (2021-2026)
  6.3.2 World Whole Exome Sequencing Service Market Size by Application (2027-2032)
  6.3.3 World Whole Exome Sequencing Service Market Size Market Share by Application (2021-2032)

7 COMPANY PROFILES

7.1 Novogene
  7.1.1 Novogene Details
  7.1.2 Novogene Major Business
  7.1.3 Novogene Whole Exome Sequencing Service Product and Services
  7.1.4 Novogene Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026)
  7.1.5 Novogene Recent Developments/Updates
  7.1.6 Novogene Competitive Strengths & Weaknesses
7.2 Eurofins Scientific
  7.2.1 Eurofins Scientific Details
  7.2.2 Eurofins Scientific Major Business
  7.2.3 Eurofins Scientific Whole Exome Sequencing Service Product and Services
  7.2.4 Eurofins Scientific Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026)
  7.2.5 Eurofins Scientific Recent Developments/Updates
  7.2.6 Eurofins Scientific Competitive Strengths & Weaknesses
7.3 CD Genomics
  7.3.1 CD Genomics Details
  7.3.2 CD Genomics Major Business
  7.3.3 CD Genomics Whole Exome Sequencing Service Product and Services
  7.3.4 CD Genomics Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026)
  7.3.5 CD Genomics Recent Developments/Updates
  7.3.6 CD Genomics Competitive Strengths & Weaknesses
7.4 Signios Bio
  7.4.1 Signios Bio Details
  7.4.2 Signios Bio Major Business
  7.4.3 Signios Bio Whole Exome Sequencing Service Product and Services
  7.4.4 Signios Bio Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026)
  7.4.5 Signios Bio Recent Developments/Updates
  7.4.6 Signios Bio Competitive Strengths & Weaknesses
7.5 Macrogen
  7.5.1 Macrogen Details
  7.5.2 Macrogen Major Business
  7.5.3 Macrogen Whole Exome Sequencing Service Product and Services
  7.5.4 Macrogen Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026)
  7.5.5 Macrogen Recent Developments/Updates
  7.5.6 Macrogen Competitive Strengths & Weaknesses
7.6 Roche
  7.6.1 Roche Details
  7.6.2 Roche Major Business
  7.6.3 Roche Whole Exome Sequencing Service Product and Services
  7.6.4 Roche Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026)
  7.6.5 Roche Recent Developments/Updates
  7.6.6 Roche Competitive Strengths & Weaknesses
7.7 BGI
  7.7.1 BGI Details
  7.7.2 BGI Major Business
  7.7.3 BGI Whole Exome Sequencing Service Product and Services
  7.7.4 BGI Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026)
  7.7.5 BGI Recent Developments/Updates
  7.7.6 BGI Competitive Strengths & Weaknesses
7.8 Psomagen
  7.8.1 Psomagen Details
  7.8.2 Psomagen Major Business
  7.8.3 Psomagen Whole Exome Sequencing Service Product and Services
  7.8.4 Psomagen Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026)
  7.8.5 Psomagen Recent Developments/Updates
  7.8.6 Psomagen Competitive Strengths & Weaknesses
7.9 Centogene
  7.9.1 Centogene Details
  7.9.2 Centogene Major Business
  7.9.3 Centogene Whole Exome Sequencing Service Product and Services
  7.9.4 Centogene Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026)
  7.9.5 Centogene Recent Developments/Updates
  7.9.6 Centogene Competitive Strengths & Weaknesses
7.10 Natera
  7.10.1 Natera Details
  7.10.2 Natera Major Business
  7.10.3 Natera Whole Exome Sequencing Service Product and Services
  7.10.4 Natera Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026)
  7.10.5 Natera Recent Developments/Updates
  7.10.6 Natera Competitive Strengths & Weaknesses
7.11 Personalis
  7.11.1 Personalis Details
  7.11.2 Personalis Major Business
  7.11.3 Personalis Whole Exome Sequencing Service Product and Services
  7.11.4 Personalis Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026)
  7.11.5 Personalis Recent Developments/Updates
  7.11.6 Personalis Competitive Strengths & Weaknesses
7.12 GENEWIZ
  7.12.1 GENEWIZ Details
  7.12.2 GENEWIZ Major Business
  7.12.3 GENEWIZ Whole Exome Sequencing Service Product and Services
  7.12.4 GENEWIZ Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026)
  7.12.5 GENEWIZ Recent Developments/Updates
  7.12.6 GENEWIZ Competitive Strengths & Weaknesses
7.13 LabCorp
  7.13.1 LabCorp Details
  7.13.2 LabCorp Major Business
  7.13.3 LabCorp Whole Exome Sequencing Service Product and Services
  7.13.4 LabCorp Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026)
  7.13.5 LabCorp Recent Developments/Updates
  7.13.6 LabCorp Competitive Strengths & Weaknesses
7.14 Brooks Life Sciences
  7.14.1 Brooks Life Sciences Details
  7.14.2 Brooks Life Sciences Major Business
  7.14.3 Brooks Life Sciences Whole Exome Sequencing Service Product and Services
  7.14.4 Brooks Life Sciences Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026)
  7.14.5 Brooks Life Sciences Recent Developments/Updates
  7.14.6 Brooks Life Sciences Competitive Strengths & Weaknesses
7.15 Illumina
  7.15.1 Illumina Details
  7.15.2 Illumina Major Business
  7.15.3 Illumina Whole Exome Sequencing Service Product and Services
  7.15.4 Illumina Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026)
  7.15.5 Illumina Recent Developments/Updates
  7.15.6 Illumina Competitive Strengths & Weaknesses
7.16 Berry Genomics
  7.16.1 Berry Genomics Details
  7.16.2 Berry Genomics Major Business
  7.16.3 Berry Genomics Whole Exome Sequencing Service Product and Services
  7.16.4 Berry Genomics Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026)
  7.16.5 Berry Genomics Recent Developments/Updates
  7.16.6 Berry Genomics Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Whole Exome Sequencing Service Industry Chain
8.2 Whole Exome Sequencing Service Upstream Analysis
8.3 Whole Exome Sequencing Service Midstream Analysis
8.4 Whole Exome Sequencing Service Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer


LIST OF TABLES

Table 1. World Whole Exome Sequencing Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Whole Exome Sequencing Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Whole Exome Sequencing Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Whole Exome Sequencing Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Whole Exome Sequencing Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Whole Exome Sequencing Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Whole Exome Sequencing Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Whole Exome Sequencing Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Whole Exome Sequencing Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Whole Exome Sequencing Service Players in 2025
Table 12. World Whole Exome Sequencing Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Whole Exome Sequencing Service Company Evaluation Quadrant
Table 14. Head Office of Key Whole Exome Sequencing Service Players
Table 15. Whole Exome Sequencing Service Market: Company Product Type Footprint
Table 16. Whole Exome Sequencing Service Market: Company Product Application Footprint
Table 17. Whole Exome Sequencing Service Mergers & Acquisitions Activity
Table 18. United States VS China Whole Exome Sequencing Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Whole Exome Sequencing Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Whole Exome Sequencing Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Whole Exome Sequencing Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Whole Exome Sequencing Service Revenue Market Share (2021-2026)
Table 23. China Based Whole Exome Sequencing Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Whole Exome Sequencing Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Whole Exome Sequencing Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based Whole Exome Sequencing Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Whole Exome Sequencing Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Whole Exome Sequencing Service Revenue Market Share (2021-2026)
Table 29. World Whole Exome Sequencing Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Whole Exome Sequencing Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Whole Exome Sequencing Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World Whole Exome Sequencing Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Whole Exome Sequencing Service Market Size by Application (2021-2026) & (USD Million)
Table 34. World Whole Exome Sequencing Service Market Size by Application (2027-2032) & (USD Million)
Table 35. Novogene Basic Information, Manufacturing Base and Competitors
Table 36. Novogene Major Business
Table 37. Novogene Whole Exome Sequencing Service Product and Services
Table 38. Novogene Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Novogene Recent Developments/Updates
Table 40. Novogene Competitive Strengths & Weaknesses
Table 41. Eurofins Scientific Basic Information, Manufacturing Base and Competitors
Table 42. Eurofins Scientific Major Business
Table 43. Eurofins Scientific Whole Exome Sequencing Service Product and Services
Table 44. Eurofins Scientific Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Eurofins Scientific Recent Developments/Updates
Table 46. Eurofins Scientific Competitive Strengths & Weaknesses
Table 47. CD Genomics Basic Information, Manufacturing Base and Competitors
Table 48. CD Genomics Major Business
Table 49. CD Genomics Whole Exome Sequencing Service Product and Services
Table 50. CD Genomics Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. CD Genomics Recent Developments/Updates
Table 52. CD Genomics Competitive Strengths & Weaknesses
Table 53. Signios Bio Basic Information, Manufacturing Base and Competitors
Table 54. Signios Bio Major Business
Table 55. Signios Bio Whole Exome Sequencing Service Product and Services
Table 56. Signios Bio Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Signios Bio Recent Developments/Updates
Table 58. Signios Bio Competitive Strengths & Weaknesses
Table 59. Macrogen Basic Information, Manufacturing Base and Competitors
Table 60. Macrogen Major Business
Table 61. Macrogen Whole Exome Sequencing Service Product and Services
Table 62. Macrogen Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Macrogen Recent Developments/Updates
Table 64. Macrogen Competitive Strengths & Weaknesses
Table 65. Roche Basic Information, Manufacturing Base and Competitors
Table 66. Roche Major Business
Table 67. Roche Whole Exome Sequencing Service Product and Services
Table 68. Roche Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Roche Recent Developments/Updates
Table 70. Roche Competitive Strengths & Weaknesses
Table 71. BGI Basic Information, Manufacturing Base and Competitors
Table 72. BGI Major Business
Table 73. BGI Whole Exome Sequencing Service Product and Services
Table 74. BGI Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. BGI Recent Developments/Updates
Table 76. BGI Competitive Strengths & Weaknesses
Table 77. Psomagen Basic Information, Manufacturing Base and Competitors
Table 78. Psomagen Major Business
Table 79. Psomagen Whole Exome Sequencing Service Product and Services
Table 80. Psomagen Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Psomagen Recent Developments/Updates
Table 82. Psomagen Competitive Strengths & Weaknesses
Table 83. Centogene Basic Information, Manufacturing Base and Competitors
Table 84. Centogene Major Business
Table 85. Centogene Whole Exome Sequencing Service Product and Services
Table 86. Centogene Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Centogene Recent Developments/Updates
Table 88. Centogene Competitive Strengths & Weaknesses
Table 89. Natera Basic Information, Manufacturing Base and Competitors
Table 90. Natera Major Business
Table 91. Natera Whole Exome Sequencing Service Product and Services
Table 92. Natera Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Natera Recent Developments/Updates
Table 94. Natera Competitive Strengths & Weaknesses
Table 95. Personalis Basic Information, Manufacturing Base and Competitors
Table 96. Personalis Major Business
Table 97. Personalis Whole Exome Sequencing Service Product and Services
Table 98. Personalis Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Personalis Recent Developments/Updates
Table 100. Personalis Competitive Strengths & Weaknesses
Table 101. GENEWIZ Basic Information, Manufacturing Base and Competitors
Table 102. GENEWIZ Major Business
Table 103. GENEWIZ Whole Exome Sequencing Service Product and Services
Table 104. GENEWIZ Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. GENEWIZ Recent Developments/Updates
Table 106. GENEWIZ Competitive Strengths & Weaknesses
Table 107. LabCorp Basic Information, Manufacturing Base and Competitors
Table 108. LabCorp Major Business
Table 109. LabCorp Whole Exome Sequencing Service Product and Services
Table 110. LabCorp Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. LabCorp Recent Developments/Updates
Table 112. LabCorp Competitive Strengths & Weaknesses
Table 113. Brooks Life Sciences Basic Information, Manufacturing Base and Competitors
Table 114. Brooks Life Sciences Major Business
Table 115. Brooks Life Sciences Whole Exome Sequencing Service Product and Services
Table 116. Brooks Life Sciences Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Brooks Life Sciences Recent Developments/Updates
Table 118. Brooks Life Sciences Competitive Strengths & Weaknesses
Table 119. Illumina Basic Information, Manufacturing Base and Competitors
Table 120. Illumina Major Business
Table 121. Illumina Whole Exome Sequencing Service Product and Services
Table 122. Illumina Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Illumina Recent Developments/Updates
Table 124. Illumina Competitive Strengths & Weaknesses
Table 125. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 126. Berry Genomics Major Business
Table 127. Berry Genomics Whole Exome Sequencing Service Product and Services
Table 128. Berry Genomics Whole Exome Sequencing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Berry Genomics Recent Developments/Updates
Table 130. Berry Genomics Competitive Strengths & Weaknesses
Table 131. Global Key Players of Whole Exome Sequencing Service Upstream (Raw Materials)
Table 132. Global Whole Exome Sequencing Service Typical Customers

LIST OF FIGURES

Figure 1. Whole Exome Sequencing Service Picture
Figure 2. World Whole Exome Sequencing Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Whole Exome Sequencing Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World Whole Exome Sequencing Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Whole Exome Sequencing Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Whole Exome Sequencing Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Whole Exome Sequencing Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Whole Exome Sequencing Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Whole Exome Sequencing Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Whole Exome Sequencing Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Whole Exome Sequencing Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Whole Exome Sequencing Service Revenue (2021-2032) & (USD Million)
Figure 13. Whole Exome Sequencing Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Whole Exome Sequencing Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World Whole Exome Sequencing Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Whole Exome Sequencing Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China Whole Exome Sequencing Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Whole Exome Sequencing Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Whole Exome Sequencing Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Whole Exome Sequencing Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Whole Exome Sequencing Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India Whole Exome Sequencing Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Whole Exome Sequencing Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Whole Exome Sequencing Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Whole Exome Sequencing Service Markets in 2025
Figure 27. United States VS China: Whole Exome Sequencing Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Whole Exome Sequencing Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Whole Exome Sequencing Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Whole Exome Sequencing Service Market Size Market Share by Type in 2025
Figure 31. Clinical Whole Exome Sequencing
Figure 32. Research Whole Exome Sequencing
Figure 33. Others
Figure 34. World Whole Exome Sequencing Service Market Size Market Share by Type (2021-2032)
Figure 35. World Whole Exome Sequencing Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 36. World Whole Exome Sequencing Service Market Size Market Share by Application in 2025
Figure 37. Hospitals
Figure 38. Biopharma Companies
Figure 39. Academic and Research Organizations
Figure 40. Others
Figure 41. World Whole Exome Sequencing Service Market Size Market Share by Application (2021-2032)
Figure 42. Whole Exome Sequencing Service Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source


More Publications